21 May 2013
Keywords: akorn, cipla, enter, accord, transplant, rejection, drug
Article | 02 July 2007
USA-based Akorn and Cipla, a leading Indian pharmaceutical company located in Mumbai, have signed an exclusive drug development and supply
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 July 2007
20 May 2013
© 2013 thepharmaletter.com